A new pill to treat HIV just got approved — and it could shake up a $22 billion market (GILD) - Bounce International - Breaking News | Latest Updates

A new pill to treat HIV just got approved — and it could shake up a $22 billion market (GILD)

- 9:00 am
advertise here

HIV infected T cellNIAID

  • The FDA just approved a new combination of drugs to treat HIV.
  • The treatment combines three drugs into one daily pill:  bictegravir, emtricitabine and tenofovir alafenamide.
  • The new approval could shake up the $22 billion HIV drug market.


The FDA just approved a new, once-a-day pill to treat HIV.

The pill, made by Gilead Sciences, contains bictegravir, along with emtricitabine and tenofovir alafenamide, two drugs that are considered the "backbone" of HIV treatments. Of the three treatments contained in the pill, bictegravir is the only totally new element. 

See the rest of the story at Business Insider

NOW WATCH: Amazon is shaking up a healthcare industry that's ripe for disruption

See Also:

SEE ALSO: 2 giant drugmakers are racing to make a breakthrough in treating HIV, and there's $22 billion on the line

DON'T MISS: The microbiome has been called the forgotten organ — and it could hold the 'next paradigm shift in science and medicine'